InMed Pharmaceuticals (INM) Share-based Compensation (2019 - 2026)
InMed Pharmaceuticals (INM) reported Share-based Compensation of $15983.0 for Q1 2026, up 2381.83% on a YoY basis from $644.0 in Q1 2025, and down 37.48% quarter-over-quarter from $25564.0 in Q4 2025.
InMed Pharmaceuticals (INM) Share-based Compensation (2019 - 2026) Analysis & Trends
InMed Pharmaceuticals has reported Share-based Compensation for 8 years, with the latest figure at $15983.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 2381.83% year-over-year to $15983.0; the trailing twelve-month figure through Mar 2026 stood at $54544.0 (down 40.53% YoY), and the FY2025 full-year result was $28964.0, down 78.97% from the prior year.
- Share-based Compensation for Q1 2026 stood at $15983.0, down from $25564.0 in the prior quarter.
- The five-year high for Share-based Compensation was $195085.0 in Q1 2022, with the low at -$7208.0 in Q2 2025.
- Historically, Share-based Compensation has averaged $52656.0 across 5 years, with a median of $28964.0 in 2024.
- Annual changes were most pronounced in 2025 — Share-based Compensation plunged 118.5% — and 2026, when it jumped 2381.83%.
- InMed Pharmaceuticals' Share-based Compensation stood at $70638.0 in 2022, then slumped by 74.14% to $18264.0 in 2023, then grew by 26.8% to $23159.0 in 2024, then gained by 10.38% to $25564.0 in 2025, then sank by 37.48% to $15983.0 in 2026.
- The last three Share-based Compensation figures came in at $15983.0 (Q1 2026), $25564.0 (Q4 2025), and $20205.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 36.86 Mn |
| 10 | InMed Pharmaceuticals | 6.00 Mn | 756,271.05 | - | 15,983.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,983.00 |
| Mar 31, 2026 | 15,983.00 |
| Dec 31, 2025 | 25,564.00 |
| Dec 31, 2025 | 25,564.00 |
| Sep 30, 2025 | 20,205.00 |
| Sep 30, 2025 | 20,205.00 |
| Jun 30, 2025 | -7,208.00 |
| Jun 30, 2025 | -7,208.00 |
| Mar 31, 2025 | 644.00 |
| Mar 31, 2025 | 644.00 |
| Dec 31, 2024 | 23,159.00 |
| Dec 31, 2024 | 23,159.00 |
| Sep 30, 2024 | 28,964.00 |
| Sep 30, 2024 | 28,964.00 |
| Jun 30, 2024 | 38,954.00 |
| Jun 30, 2024 | 38,954.00 |
| Mar 31, 2024 | 55,305.00 |
| Mar 31, 2024 | 55,305.00 |
| Dec 31, 2023 | 18,264.00 |
| Dec 31, 2023 | 18,264.00 |